documents: FDA-2018-N-3240-0375
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2018-N-3240-0375 | FDA | FDA-2018-N-3240 | Reference 3 - Part 1 Evaluation for Hydroxychloroquine Sulfate RE List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act | Supporting & Related Material | Background Material | 2023-08-23T04:00:00Z | 2023 | 8 | 2023-08-23T20:14:40Z | 0 | 0 | 0900006485edb7aa |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref